NEW YORK (CBS.MW) -- GTx, a Memphis-based company that bills itself as a biotech company aimed at men's health, filed to raise up to $86.25 million in an initial public offering. Elsewhere in the IPO ...
Dec 26 (Reuters) - Biopharmaceutical company GTx Inc said in a regulatory filing that it may periodically sell up to $100 million in debt securities, common and preferred stock, warrants and units.
NEW YORK (CBS.MW) -- GTX Inc. on Thursday set plans to offer 5.4 million shares at $13-$15 each in a bid to raise about $81 million with underwriter Goldman Sachs . The Memphis-based maker of drugs to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback